{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:35:02Z","timestamp":1789842902002,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jacl.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T09:15:40Z","timestamp":1213434940000},"page":"237-247","source":"Crossref","is-referenced-by-count":35,"title":["Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein\u2013deficiency states"],"prefix":"10.1016","volume":"2","author":[{"given":"Raul D.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela F.","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilton R.C.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio H.","family":"Miname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Polisecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(78)91863-9","article-title":"Plasma-triglycerides in regulation of HDL-cholesterol levels","volume":"2","author":"Schaefer","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0016-5085(85)90642-0","article-title":"Lipoprotein abnormalities in primary biliary cirrhosis: association with hepatic lipase inhibition as well as altered cholesterol esterification","volume":"89","author":"Jahn","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacl.2007.02.003","article-title":"Severe acquired (secondary) high-density lipoprotein deficiency","volume":"1","author":"Goldberg","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/bi011716p","article-title":"Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I","volume":"41","author":"Bielicki","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jacl.2008.06.002_bib5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0002-9149(91)90924-A","article-title":"Prevalence of risk factors in men with premature coronary artery disease","volume":"67","author":"Genest","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Prevalence of familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/01.ATV.13.12.1728","article-title":"Familial hypoalphalipoproteinemia in premature coronary artery disease","volume":"13","author":"Genest","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacl.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.285.12.1585","article-title":"Relation of gemfibrozil treatment and lipid levels with major coronary events","volume":"285","author":"Robins","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.162.22.2597","article-title":"Diabetes, plasma insulin, and cardiovascular disease","volume":"162","author":"Rubins","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.ATV.2.1.16","article-title":"Plasma apolipoprotein A-I absence associated with marked reduction of high density lipoproteins and premature coronary artery disease","volume":"2","author":"Schaefer","year":"1982","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.ATV.4.4.303","article-title":"The clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency","volume":"4","author":"Schaefer","year":"1984","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.1967.00470250005001","article-title":"Neuropathy in Tangier disease","volume":"17","author":"Engel","year":"1967","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jacl.2008.06.002_bib15","first-page":"101","article-title":"The pathology of Tangier disease","volume":"78","author":"Ferrans","year":"1975","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacl.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1172\/JCI108761","article-title":"Isolation and characterization of an abnormal high density lipoprotein in Tangier Disease","volume":"60","author":"Assmann","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2275(20)34282-6","article-title":"Apolipoprotein A-I and C-III deficiency, variant II","volume":"26","author":"Schaefer","year":"1985","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib18","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1016\/S0021-9258(19)84708-7","article-title":"Familial apolipoprotein A-I, C-III, and A-IV deficiency with marked high density lipoprotein deficiency and premature atherosclerosis due to a deletion of the apolipoprotein A-I, C-III, and A-IV gene complex","volume":"264","author":"Ordovas","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJM198206243062503","article-title":"Familial deficiency of apolipoproteins A-I and C-III and precocious coronary artery disease","volume":"306","author":"Norum","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/301718a0","article-title":"An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis","volume":"301","author":"Karathanasis","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2008.06.002_bib21","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1073\/pnas.84.20.7198","article-title":"DNA inversion within the apolipoprotein AI\/CIII\/AIV-encoding gene cluster of certain patients with premature atherosclerosis","volume":"84","author":"Karathanasis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2008.06.002_bib22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/0024-3205(83)90643-4","article-title":"Effect of blood high density lipoprotein cholesterol concentration on fecal steroid excretion in humans","volume":"32","author":"Beher","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.jacl.2008.06.002_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI111576","article-title":"Familial apolipoprotein AI and apolipoprotein CIII deficiency","volume":"74","author":"Forte","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI112713","article-title":"Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI","volume":"78","author":"Ginsberg","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0022-2275(20)41645-1","article-title":"Effect of apolipoprotein activators on the specificity lecithin:cholesterol acyltransferase: determination of cholesteryl esters formed in A-I\/C-III deficiency","volume":"32","author":"Subbaiah","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0022-2275(20)41644-X","article-title":"Characterization of apoA-I and apoB containing lipoprotein particles in a variant of familial apolipoprotein A-I deficiency with planar xanthomas: the metabolic significance of LP-A-II particles","volume":"32","author":"Bekaert","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/clc.4960090709","article-title":"Deficiency of apolipoproteins A-I and C-III and severe coronary artery disease","volume":"9","author":"Hiasa","year":"1986","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacl.2008.06.002_bib28","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1073\/pnas.88.7.2793","article-title":"Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene","volume":"88","author":"Matsunaga","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI116949","article-title":"Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein deficiency in a family with analphalipoproteinemia","volume":"93","author":"Ng","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-199607000-00006","article-title":"Case report: retinopathy and neuropathy associated with complete apolipoprotein A-I deficiency","volume":"312","author":"Ng","year":"1996","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacl.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1194\/jlr.M700362-JLR200","article-title":"Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency","volume":"46","author":"Santos","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.ATV.19.2.348","article-title":"Compound heterozygozity for an apolipoprotein AI gene promoter mutation and a structural nonsense mutation with apolipoprotein deficiency","volume":"19","author":"Matsunaga","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2008.06.002_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2003.09.024","article-title":"A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease","volume":"172","author":"Ikewaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib34","doi-asserted-by":"crossref","first-page":"13654","DOI":"10.1016\/S0021-9258(18)92750-X","article-title":"A mutation in the apolipoprotein A-I gene","volume":"266","author":"Deeb","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2008.06.002_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0021-9150(03)00020-0","article-title":"Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency","volume":"167","author":"Pisciotta","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-55-6-1016","article-title":"Tangier disease","volume":"55","author":"Fredrickson","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2008.06.002_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-93-2-261","article-title":"Coronary heart disease prevalence and other clinical features in familial high density lipoprotein deficiency (Tangier disease)","volume":"93","author":"Schaefer","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2008.06.002_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9150(94)90144-9","article-title":"Homozygous Tangier disease and cardiovascular disease","volume":"107","author":"Serfaty-Lacrosniere","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib39","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/archopht.1979.01020020374020","article-title":"Ocular manifestations of familial high density lipoprotein deficiency (Tangier disease)","volume":"97","author":"Chu","year":"1979","journal-title":"Arch Opthalmol"},{"key":"10.1016\/j.jacl.2008.06.002_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9150(00)00643-2","article-title":"Subpopulations of high-density lipoproteins in homozygous and heterozygous Tangier disease","volume":"156","author":"Asztalos","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.ATV.15.5.683","article-title":"HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients","volume":"15","author":"Rogler","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2008.06.002_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI118082","article-title":"Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease","volume":"96","author":"Francis","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2008.06.002_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/bbrc.1999.0406","article-title":"Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages","volume":"257","author":"Langmann","year":"1999","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.jacl.2008.06.002_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutation in ABC1 in Tangier disease and familial high density lipoprotein","volume":"22","author":"Brooks","year":"1999","journal-title":"Nature Gen"},{"key":"10.1016\/j.jacl.2008.06.002_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nature Gen"},{"key":"10.1016\/j.jacl.2008.06.002_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nature Gen"},{"key":"10.1016\/j.jacl.2008.06.002_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-2275(20)34482-5","article-title":"Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds","volume":"41","author":"Brousseau","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib49","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0022-2275(20)32019-8","article-title":"Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size","volume":"41","author":"Brousseau","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0021-9150(01)00688-8","article-title":"Cholesterol and apolipoprotein B metabolism in Tangier disease","volume":"159","author":"Schaefer","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2008.06.002_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/00365516709076948","article-title":"Familial plasma lecithin cholesterol acyl transferase deficient","volume":"20","author":"Norun","year":"1967","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jacl.2008.06.002_bib52","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","article-title":"The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families","volume":"25","author":"Calabresi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2008.06.002_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1194\/jlr.M600403-JLR200","article-title":"Role of LCAT in HDL remodeling: investigation of LCAT deficiency states","volume":"48","author":"Asztalos","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib54","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1 and SRB1-mediated cholesterol efflux","volume":"46","author":"Asztalos","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2008.06.002_bib55","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.ATV.0000146325.93749.a8","article-title":"High density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants in the Framingham Offspring Study","volume":"24","author":"Asztalos","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2008.06.002_bib56","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.ATV.0000183727.90611.4f","article-title":"Value of high density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial","volume":"25","author":"Asztalos","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2008.06.002_bib57","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.ATV.0000066133.32063.BB","article-title":"Change in alpha 1 HDL concentration predicts progression in coronary artery stenosis","volume":"23","author":"Asztalos","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287408002638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287408002638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T04:43:29Z","timestamp":1631421809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287408002638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1933287408002638"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2008.06.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}